EW HEALTHCARE PARTNERS FUND 2, L.P. - 17 Sep 2021 Form 4 Insider Report for TELA Bio, Inc. (TELA)

Role: Other*
Signature: EW HEALTHCARE PARTNERS FUND 2, L.P., By: EW Healthcare Partners Fund 2 GP, L.P., its General Partner, By: EW Healthcare Partners Fund 2-UGP, LLC, its General Partner, By: Martin P. Sutter, Attorney-in-Fact, /s/ Martin P. Sutter
Issuer symbol: TELA
Transactions as of: 17 Sep 2021
Net transactions value: +$15,684
Form type: 4
Filing time: 21 Sep 2021, 17:41:10 UTC
Previous filing: 20 Sep 2021
Next filing: 23 Sep 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TELA	Common Stock, par value $0.001 per share	Purchase	$4,060	+322	+0.02%	$12.61	1,832,370	17 Sep 2021	See footnotes	F1, F2
transaction	TELA	Common Stock, par value $0.001 per share	Purchase	$11,624	+924	+0.05%	$12.58	1,833,294	20 Sep 2021	See footnotes	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares shown above were the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 363 shares of the amount shown above on September 20, 2021, and Fund 2-A purchased 322 shares and 561 shares of the amounts shown above for September 17 and September 20, 2021, respectively. Fund 2 now holds a total of 761,523 shares and Fund 2-A now holds a total of 1,071,771 shares of the Issuer.
F2	EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Content

Shares shown above were the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 363 shares of the amount shown above on September 20, 2021, and Fund 2-A purchased 322 shares and 561 shares of the amounts shown above for September 17 and September 20, 2021, respectively. Fund 2 now holds a total of 761,523 shares and Fund 2-A now holds a total of 1,071,771 shares of the Issuer.

EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein.